{"id":"https://openalex.org/W2132001275","doi":"https://doi.org/10.1016/j.clpt.2004.04.011","title":"Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans","display_name":"Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans","publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W2132001275","doi":"https://doi.org/10.1016/j.clpt.2004.04.011","mag":"2132001275","pmid":"https://pubmed.ncbi.nlm.nih.gov/15371980"},"language":"en","primary_location":{"id":"doi:10.1016/j.clpt.2004.04.011","doi":"https://doi.org/10.1016/j.clpt.2004.04.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clpt.2004.04.011","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111976152","display_name":"Thomas Gie\u00dfmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"T GIESSMANN","raw_affiliation_strings":["Department of Clinical Pharmacology, Peter Holtz Reaearch Center of Pharmacology & Experiental Therapeutics, University of Greifswald, Friedrich-Loeffler-Strasse 23d, D-17487 Greifswald, Germany","Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Peter Holtz Reaearch Center of Pharmacology & Experiental Therapeutics, University of Greifswald, Friedrich-Loeffler-Strasse 23d, D-17487 Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]},{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113669373","display_name":"K. May","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"K MAY","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028540012","display_name":"Christiane Mode\u00df","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"C MODESS","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020529679","display_name":"Danilo Wegner","orcid":"https://orcid.org/0000-0002-3719-1336","observed_orcids":["https://orcid.org/0000-0002-3719-1336"]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"D WEGNER","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009466367","display_name":"Ute Hecker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"U HECKER","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111702949","display_name":"Michael Zschiesche","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M ZSCHIESCHE","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002102670","display_name":"Peter Dazert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"P DAZERT","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054013279","display_name":"Markus Grube","orcid":"https://orcid.org/0009-0001-8076-6270","observed_orcids":["https://orcid.org/0009-0001-8076-6270"]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M GRUBE","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050126564","display_name":"Eike Schroeder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"E SCHROEDER","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040628826","display_name":"R Warzok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36522303","display_name":"Universit\u00e4t Greifswald","ror":"https://ror.org/00r1edq15","country_code":"DE","type":"education","lineage":["https://openalex.org/I36522303"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"R WARZOK","raw_affiliation_strings":["Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Clinical Pharmacology and Pharmacology, Peter Holtz Research Center of Pharmacology and Experimental Therapeutics, and Departments of Internal Medicine and Pathology, University of Greifswald, Greifswald, Germany","institution_ids":["https://openalex.org/I36522303"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I36522303"],"apc_list":{"value":4410,"currency":"USD","value_usd":4410},"apc_paid":null,"fwci":5.4376,"has_fulltext":false,"cited_by_count":168,"citation_normalized_percentile":{"value":0.96565352,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":99},"biblio":{"volume":"76","issue":"3","first_page":"192","last_page":"200"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9039999842643738},{"id":"https://openalex.org/keywords/mrp2","display_name":"MRP2","score":0.8539999723434448},{"id":"https://openalex.org/keywords/multidrug-resistance-protein","display_name":"multidrug resistance protein","score":0.7459999918937683},{"id":"https://openalex.org/keywords/mdr1-mrna-expression","display_name":"MDR1 mRNA expression","score":0.6620000004768372},{"id":"https://openalex.org/keywords/talinolol","display_name":"talinolol","score":0.75},{"id":"https://openalex.org/keywords/drug-disposition","display_name":"drug disposition","score":0.6470000147819519},{"id":"https://openalex.org/keywords/intestinal-drug-transporters","display_name":"intestinal drug transporters","score":0.7540000081062317},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6060000061988831},{"id":"https://openalex.org/keywords/oral-absorption","display_name":"oral absorption","score":0.39500001072883606},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.5899999737739563},{"id":"https://openalex.org/keywords/glucuronidation","display_name":"glucuronidation","score":0.6370000243186951},{"id":"https://openalex.org/keywords/pregnane-x-receptor","display_name":"pregnane X receptor","score":0.6759999990463257},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7749999761581421},{"id":"https://openalex.org/keywords/concomitant-medications","display_name":"concomitant medications","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C36201501","wikidata":"https://www.wikidata.org/wiki/Q17907816","display_name":"Multidrug resistance-associated protein 2","level":5,"score":0.9435839653015137},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.7593536972999573},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.7458567023277283},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5662876963615417},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5597690343856812},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5184237957000732},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4995737075805664},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4596289396286011},{"id":"https://openalex.org/C2776769776","wikidata":"https://www.wikidata.org/wiki/Q900898","display_name":"Probenecid","level":2,"score":0.4456014037132263},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4265996515750885},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.42018646001815796},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.3464711308479309},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.32458317279815674},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28929856419563293},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.26669028401374817},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.25821584463119507},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15990865230560303},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.10838896036148071},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.0},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000089762","descriptor_name":"Multidrug Resistance-Associated Protein 2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005786","descriptor_name":"Gene Expression Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D026901","descriptor_name":"Membrane Transport Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D027425","descriptor_name":"ATP-Binding Cassette, Sub-Family C Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D051544","descriptor_name":"Cytochrome P-450 CYP3A","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.clpt.2004.04.011","doi":"https://doi.org/10.1016/j.clpt.2004.04.011","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.clpt.2004.04.011","pdf_url":null,"source":{"id":"https://openalex.org/S159852663","display_name":"Clinical Pharmacology & Therapeutics","issn_l":"0009-9236","issn":["0009-9236","1085-8733","1532-6535"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:15371980","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15371980","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical pharmacology and therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W38278793","https://openalex.org/W50867720","https://openalex.org/W1545401674","https://openalex.org/W1787076927","https://openalex.org/W1943747111","https://openalex.org/W1956099131","https://openalex.org/W1968535758","https://openalex.org/W1971604750","https://openalex.org/W1999764231","https://openalex.org/W2002345475","https://openalex.org/W2003879898","https://openalex.org/W2022545732","https://openalex.org/W2033336706","https://openalex.org/W2034664377","https://openalex.org/W2042802531","https://openalex.org/W2050034374","https://openalex.org/W2063124482","https://openalex.org/W2076985436","https://openalex.org/W2082427007","https://openalex.org/W2084462922","https://openalex.org/W2090632754","https://openalex.org/W2091580103","https://openalex.org/W2098293164","https://openalex.org/W2101610746","https://openalex.org/W2106300667","https://openalex.org/W2110980033","https://openalex.org/W2112533311","https://openalex.org/W2117927958","https://openalex.org/W2125457175","https://openalex.org/W2127377575","https://openalex.org/W2133837027","https://openalex.org/W2143764289","https://openalex.org/W2145766137","https://openalex.org/W2154310483","https://openalex.org/W2155033804","https://openalex.org/W2155568044","https://openalex.org/W2439732485"],"related_works":["https://openalex.org/W2964953413","https://openalex.org/W2082427007","https://openalex.org/W2908959053","https://openalex.org/W2117927958","https://openalex.org/W2062100934","https://openalex.org/W2112533311","https://openalex.org/W1879832764","https://openalex.org/W1956099131","https://openalex.org/W2355405292","https://openalex.org/W2377824285"],"abstract_inverted_index":{"BACKGROUND":[0],"AND":[1],"METHODS:":[2],"The":[3],"antiepileptic":[4],"drug":[5],"carbamazepine":[6,103,124,214,276],"is":[7],"known":[8],"to":[9,20],"be":[10],"an":[11,279],"inducer":[12,280],"of":[13,47,60,66,102,118,123,133,173,208,274,281],"cytochrome":[14],"P450":[15],"(CYP)":[16],"3A4":[17],"after":[18,72,100,213],"binding":[19],"the":[21,32,67,141,148],"nuclear":[22],"pregnane":[23],"X":[24],"receptor.":[25],"To":[26],"evaluate":[27],"whether":[28],"it":[29],"also":[30],"regulates":[31],"multidrug":[33,39,48],"transporter":[34],"proteins":[35],"P-glycoprotein":[36],"(P-gp)":[37],"and":[38,56,62,64,76,99,121,137,140,157,196,225,228,247,254,263,287],"resistance":[40,49],"protein":[41,143,289],"MRP2":[42,57,138,197,255,285,288],"in":[43,87,184,235],"humans,":[44],"duodenal":[45],"expression":[46,132,156,160,189,199],"gene":[50],"MDR1":[51,135,154,187,239,283],"messenger":[52],"ribonucleic":[53],"acid":[54,120],"(mRNA)":[55],"mRNA,":[58,284,286],"content":[59,150],"P-gp":[61,69,149],"MRP2,":[63],"disposition":[65],"nonmetabolized":[68],"substrate":[70],"talinolol":[71,175,209],"intravenous":[73,174],"(30":[74],"mg)":[75],"long-term":[77],"oral":[78],"administration":[79],"(100":[80],"mg":[81,105],"for":[82,106],"19":[83],"days)":[84],"were":[85,161,231],"assessed":[86],"7":[88],"healthy":[89],"subjects":[90],"(age,":[91],"23-35":[92],"years;":[93],"body":[94],"weight,":[95],"64-93":[96],"kg)":[97],"before":[98],"comedication":[101,215],"(600":[104],"14-18":[107],"days).":[108],"RESULTS:":[109],"Carbamazepine":[110],"medication":[111],"was":[112,128,144,151,176,181,210],"associated":[113],"with":[114,238],"increased":[115],"urinary":[116],"excretion":[117],"D-glucaric":[119],"induction":[122,273],"elimination.":[125],"Creatinine":[126],"clearance":[127,172,180,227,230],"not":[129,152],"affected.":[130,153],"Duodenal":[131],"both":[134],"mRNA":[136,139,155,159,188,198,240,256],"MPR2":[142,158],"significantly":[145,177,182,211,232],"induced,":[146],"whereas":[147],"correlated":[162,234],"(":[163,190,200,241,257],"r":[164,191,201,242,248,258,264],"=":[165,192,202,243,249,259,265],"0.873,":[166],"P":[167,194,204,223,245,251,261,267],"<.001).":[168],"After":[169],"carbamazepine,":[170],"metabolic":[171,229],"increased.":[178],"Residual":[179],"decreased":[183],"dependence":[185],"on":[186],"-0.647,":[193],"=.012)":[195],"-0.613,":[203],"=.020).":[205],"Oral":[206],"absorption":[207],"lower":[212],"(53.2%":[216],"+/-":[217,221],"15.5%":[218],"versus":[219],"62.1%":[220],"13.0%,":[222],"=.018),":[224],"renal":[226],"increased,":[233],"each":[236],"case":[237],"0.612,":[244],"=.020,":[246],"0.554,":[250],"=.040,":[252],"respectively)":[253],"0.596,":[260],"=.025,":[262],"0.565,":[266],"=.035,":[268],"respectively).":[269],"CONCLUSIONS:":[270],"Aside":[271],"from":[272],"CYP3A4,":[275],"acts":[277],"as":[278],"intestinal":[282],"content.":[290]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}